Summary
The (Ca2+ + Mg2+) ATPase which serves as a Ca2+ pump in the kidney basolateral membranes is essential to the maintenance of an intracellular Ca2+ concentration optimal for kidney function. Since atrial natriuretic peptide (ANP) is known to participate in the Ca2+ homeostasis mechanism, altered levels of ANP in diabetes may vary the pump activity and consequently the kidney function. In order to examine the modulatory role of ANP on (Ca2+ + Mg2+) ATPase in short- (6 weeks) and long-term (6 months) diabetes, rats were injected with streptozotocin (65 mg/kg body wt, i.v.). At 6 weeks, the plasma ANP was decreased whereas, ANP-receptor binding in the kidney basolateral membrane was increased. In contrast, there was an increased plasma ANP and decreased ANP receptor binding at 6 months. Insulin treatment to diabetic animals normalized these parameters. The (Ca2+ + Mg2+) ATPase activity was unchanged both at 6 weeks and 6 months. Our results demonstrate that the unchanged Ca2+ pump activity in short-term and long-term diabetes serves to maintain the Ca2+ homeostasis in the kidney cells and thus may maintain the hyperfiltration state in diabetes. Unaltered (Ca2+ + Mg2+) ATPase is achieved by the initial up-regulation and subsequent down-regulation of the ANP receptors.
Similar content being viewed by others
References
Penniston JT: Plasma membrane Ca2+ ATPase as active Ca2+ pumps. In: W Cheung (ed.) Calcium and Cell Function, vol 3. San Diego, CA, Academic Press, 1983, pp 100–138
Carafoli E, Zurini M, Benaim G: The calcium pump of plasma membranes. In: D Evered and J Whelan (ed.) Calcium and the Cell (Ciba Foundation Symposium 122). Chichester, UK, Wiley, 1986, pp 58–72
Murer H, Gmaj P: Transport studies in plasma membrane vesicles isolated from renal cortex. Kidney Int 30: 171–186, 1986
Kinne-Saffran E, Kinne R: Localization of a calcium-stimulated ATPase in the basal-lateral plasma membranes of the proximal tubule of rat kidney cortex. J Membr Biol 17: 263–274,1974
De Smedt H, Parys JB, Borghgraef R, Wuytack F: Phosphorylated intermediates of (Ca2+ + Mg2+)-ATPase and alkaline phosphatase in renal plasma membranes. Biochim Biophys Acta 728: 409–418, 1983
Huang CL, Lewicki J, Johnson LK, Cogan MC: Renal mechanism of action of rat atrial natriuretic factor. J Clin Invest 75: 769–773, 1985
Maack T, Camargo MJF, Kleinert HD, Laragh JH, Atlas SA: Atrial natriuretic factor: structure and functional properties. Kidney Int 27: 607–615, 1985
Cogan MG: Atria] natriuretic factor can increase renal solute excretion primarily by raising glomerular filtration. Am J Physiol 250: F710-F714, 1986
Dunn BR, Ichikawa I, Pfeffer J, Troy JL, Brenner BM: Renal and systemic hemodynamic effects of synthetic atrial natriuretic peptide in the anaesthetized rat. Circ Res 59: 237–246,1986
Sosa RE, Volpe M, Marion DN, Atlas SA, Laragh JH, Vaughan BD Jr, Maack T: Relationship between renal hemodynamic and natriuretic effects of atrial natriuretic factor. Am J Physiol 250: F520–524, 1986
Ortola FV, Ballerman BJ, Anderson S, Mender RE, Brenner BM: Elevated plasma atrial natriuretic peptide levels in diabetic rats. Potential mediator of hyperfiltration. J Clin Invest 80: 670–674, 1987
Bell GM, Bernstein RK, Laragh JH: Increased plasma atrial natriuretic factor and reduced plasma renin in patients with poorly controlled diabetes mellitus. Clin Sci 77: 177–182,1989
Todd ME, Hebden RA, Gowen B, Tang C, McNeill JH: Atrial structure and plasma ANF levels in rats with chronic diabetes mellitus. Diabetes 39: 483–489, 1990
Hassid A: Atriopeptin II decreases cytosolic free Ca in cultured vascular smooth muscle cells. Am J Physiol 251: C681-C686,1986
Penniston J, Graf E, Niggli V: The plasma membrane calcium ATPase. In: F Brouner, Kleinzeller A (ed.) Calciumbinding Proteins: Structure and Function, Academic Press, Inc., New York, 1980, pp 23–30
Sahai A, Ganguly PK: Lack of response of (Ca2+ + Mg2+) ATPase to atrial natriuretic peptide in basolateral membranes from kidney cortex of chronic diabetic rats. Biochem Biophys Res Commun 169: 537–544, 1990
Ganguly PK, Dhalla KS, Innes IR, Beamish RE, Dhalla NS: Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy. Circ Res 59: 684–693, 1986
Lang RE, Thölken H, Ganten D, Luft FC, Ruskoaha H, Unger TL: Atrial natriuretic factor-a circulating hormone stimulated by volume overloading. Nature (Lond) 314: 264–266,1985
Schwab SJ, Klahr, Hammerman MR: Na2+ gradient dependent and sodium plus potassium gradient-dependent L-glutamate uptake in renal basolateral membrane vesicles. J Membr Biol 60: 63–71, 1981
Ganguly PK, Pierce GN, Dhalla KS, Dhalla NS: Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy. Am J Physiol 244: E528-E535, 1983
Mogensen CE, Andersen MJF: Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 22: 706–712, 1973
Wald H, Scherzer P, Popovtzer MM: Enhanced renal tubular ouabain-sensitive ATPase in streptozotocin diabetes mellitus. Am J Physiol 251: F164–170, 1986
Ku DD, Sellers BM, Meezan E: Development of renal hypertrophy and increased renal Na, K-ATPase in streptozotocin-diabetic rats. Endocrinology 119: 672–679, 1986
Ku DD, Meezan E: Increased renal tubular sodium pump and Na2+, K+ adenosine triphosphatase in streptozotocindiabetic rats. J Pharmacol Exp Ther 229: 664–670, 1984
Michels LD, O'Donnell MP, Keane WF: Glomerular hemodynamic and structural correlations in long-term experimental diabetic rats. J Lab Clin Med 103: 840–847, 1984
Sahai A, Ganguly PK: Congestive heart failure in diabetes with hypertension may be due to uncoupling of the ANP receptor-effector system in kidney basolateral membrane. Am Heart J (in press)
Haupert GT Jr: Endogenous Na, K-ATPase inhibitor(s) and atrial natriuretic peptides: Are they interrelated? Prog Biochem Pharmacol 23: 71–76, 1988
Ku DD, Roberts RB, Sellers BM, Meezan E: Regression of renal hypertrophy and elevated renal Na+, K+-ATPase activity after insulin treatment in streptozotocin-diabetic rats. Endocrinology 120: 2166–2173, 1987
Levy J, Grunberger G, Karl I, Gavin III JR: Effects of food restriction and insulin treatment on (Ca2+ + Mg2+) ATPase: Response to insulin in kidney basolateral membranes of non insulin-dependent diabetic rats. Metabolism 39 No 1: 25–33,1990
Levy J, Gavin III JR, Hammerman MR, Avioli LV: (Ca2+ + Mg2+) ATPase activity in kidney basolateral membrane in noninsulin-dependent diabetic rats: Effect of insulin. Diabetes 35: 889–905, 1986
Fiscus RR, Robles BT, Waldman SA, Murad F: Atrial natriuretic factors stimulate accumulation and efflux of cyclic GMP in C6–2B rat glioma and PC12 rat pheochromocytoma cell cultures. J Neurochem 48: 522–528, 1987
Weishaar RE, Kobylarz-Singer DC, Keiser J, Haleen SJ, Major TC, Rapundalo S, Peterson JT, Panek R: Subclasses of cyclic GMP-specific phosphodiesterase and their role in regulating the effects of atria] natriuretic factor. Hypertension 15: 528–540, 1990
Morley JE, Levine AS, Brown DM, Handwerger BS: Calmodulin levels in diabetic mice. Biochem Biophys Res Commun 108:1418–1423,1982
Van Heeswijk MPE, Geertsen JAM, Van Os CH: Kinetic properties of the ATP-dependent Ca2+ pump and the Na+/Ca2+ exchange system in basolateral membranes from rat kidney cortex. J Membran Biol 79: 19–31, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sahai, A., Ganguly, P.K. (Ca2+ + Mg2+) ATPase activity in kidney basolateral membrane in diabetes: role of atrial natriuretic peptide. Mol Cell Biochem 105, 15–20 (1991). https://doi.org/10.1007/BF00230370
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00230370